Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Current NASH Treatments

Hear Philip N. Newsome, PhD, FRCPE, discuss available approaches to managing NASH, including lifestyle, vitamin E, and compounds that target insulin resistance.
Philip N. Newsome, PhD, FRCPE
Released: July 2, 2020

Hear Philip N. Newsome, PhD, FRCPE, discuss available approaches to managing NASH, including lifestyle, vitamin E, and compounds that target insulin resistance, including:

  • Recommended Pharmacologic Therapies for NASH
    • Pioglitazone
    • Vitamin E
  • Optimal Diabetes Therapies in NAFLD/NASH
    • Weight Loss
    • Liver Health
  • Surgical Approaches to Weight Loss and Effect on Liver

Download the slides from this podcast at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics/management-approaches-with-currently-available-treatments/slideset

See more NASH topics at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics

Acknowledgements

Provided by the American Gastroenterology Association.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Endocrine Society Logo
Supported by educational grants from
Allergan
Gilead Sciences
Intercept Pharmaceuticals, Inc.

Related Content

On-demand webcast featuring an expert panel with insight on new data presented at ECCO 2022 for Crohn disease and ulcerative colitis from Clinical Care Options (CCO)

Uma Mahadevan, MD Bruce E. Sands, MD, MS Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: May 19, 2022 Expired: May 18, 2023

Clinical Care Options (CCO) presents expert commentary on new data in Crohn disease and ulcerative colitis from ECCO 2022

Bruce E. Sands, MD, MS Released: May 13, 2022

Expert slides from Clinical Care Options (CCO) on new data from ECCO 2022 17th Congress Meeting in patients with Crohn disease and ulcerative colitis

Uma Mahadevan, MD Bruce E. Sands, MD, MS Released: May 6, 2022

Clinical Care Options (CCO) presents Dr. Jane Jeffrie Seley discussing the importance of patient education and training when managing T2D treatment in older patients

Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES Released: May 4, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings